ArticleCPT: pharmacometrics & systems pharmacology2026

Development of an Agent-Based Model to Investigate Durability of Factor IX Activity in Hemophilia B Patients Treated With Etranacogene Dezaparvovec.

Yuezhe Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.